Webinar: CAR-T Cell Therapy for Generalized Myasthenia Gravis: Introduction to anito-cel

Webinar: CAR-T Cell Therapy for Generalized Myasthenia Gravis: Introduction to anito-cel

When

August 21, 2025    
1:00 pm

Thursday, August 21, 2025 1:00 PM Eastern Time / 10:00 AM Pacific Time

Presenter:  Dr. Chris Heery, Chief Medical Officer, Arcellx

Join us to learn about anito-cel, a novel BCMA-targeted DNA CAR T-cell therapy that is being developed by Arcellx for generalized myasthenia gravis (gMG). Dr. Chris Heery, Chief Medical Officer at Arcellx, will explain how CAR T-cell therapy works and introduce the clinical trial of anito-cel in gMG.

This webinar is sponsored by Arcellx.

Register